Barnaamijka DTP ee CaryHealth wuxuu fududeeyaa habka daaweynta Natroba (echinococcin) isagoo ku beddelaya hababka kala duwan ee daryeelka internetka qaab aan kala go 'lahayn oo bukaanka diiradda saaraya.
WASHINGTON, Abriil 7, 2026 — (BUSINESS WIRE) — CaryHealth, oo ah shirkad hormuud u ah caafimaadka dijitaalka ah, ayaa maanta ku dhawaaqday iskaashi ay la leedahay Cipher Pharmaceuticals US LLC (Cipher ama Cipher Pharmaceuticals) si ay u bilowdo barnaamijkeeda tooska ah ee bukaan-socodka (DTP), oo loogu talagalay in bukaanada la siiyo marin fudud oo ay ku helaan daawada dhakhtarku qoro ee Natroba (spinosad), oo loo isticmaalo daaweynta injirta madaxa iyo finanka. Iyada oo qayb ka ah iskaashigan, CaryHealth waxay samaysay barnaamij khadka tooska ah oo loo habeeyey kaas oo u oggolaanaya bukaanada inay si dhakhso ah u galaan oo ay u qaataan Natroba (spinosad), taasoo meesha ka saaraysa caqabadaha caadiga ah ee ay bukaanadu la kulmaan marka ay isticmaalayaan adeegyada caafimaadka ee dalwaddu.
"Qoysaska wajahaya injirta iyo finanka waxay u baahan yihiin xal degdeg ah oo fudud si ay u helaan daawooyinka ugu fiican uguna waxtarka badan ee dhakhtarku qoro," ayuu yiri Brian Jacobs, Madaxweynaha Hawlgallada Mareykanka ee Cipher Pharmaceuticals. "Iyada oo loo marayo iskaashiga aan la leenahay CaryHealth, waxaan bixinnaa qaadashada wadada dhinaceeda ama keenista guriga, taasoo ka dhigaysa mid u fudud oo dhaqso badan bukaanada inay helaan Natroba™ ama nooca shatiga leh ee guud, spinosad. Daawooyinka farmashiyaha dhaqameed hadda ma shaqeeyaan, laakiin daawada dhakhtarku qoro ee Natroba™ (spinosad) waxay bixisaa gargaar degdeg ah oo ka yimaada injirta iyo finanka."
"Cipher wuxuu qaadayaa tallaabo geesinimo leh oo diiradda saareysa bukaanka isagoo maalgelinaya qaab daryeel caafimaad oo mideysan oo dhijitaal ah," ayuu yiri Areo Nazari, oo ah madaxa shirkadda CaryHealth. "Annagoo isku darayna daawooyinka dhakhtarku qoro, isdhexgalka dhakhtarka, iyo adeegyada farmashiyaha (oo ay ku jiraan gaarsiinta) hal khibrad, waxaan ka caawin karnaa qoysaska inay dib ugu soo laabtaan caadi, laga bilaabo waqtiga ay raadinayaan daryeel ilaa waqtiga ay si guul leh u daaweeyaan."
CaryHealth waxay samaysay xal isku dhafan, aan kala go 'lahayn, oo dhammaystiran oo loogu talagalay daryeelka bukaanka tooska ah ee Natroba™ (echinococcin), iyadoo wanaajinaysa khibradda daryeelka guud iyadoo yaraynaysa waqtiyada gelitaanka iyo baabi'inta caqabadaha. Xalkani wuxuu meesha ka saarayaa hababka daryeelka internetka ee kala go'an, gelitaanka badan, iyo tallaabooyinka lacag bixinta ee kala duwan, taasoo u oggolaanaysa bukaanada inay helaan daawooyin caafimaad oo si fog loo qoray, ku raaxaystaan dhammaantood isla maalintaas laga keenay farmashiyeyaasha dalka oo dhan ee aagga adeegga CaryRx, iyo inay la socdaan xaaladda daawada waqtiga dhabta ah iyada oo loo marayo bogga CaryConnect.
CaryHealth waa shirkad tiknoolajiyadeed oo dhijitaal ah oo dawooyinka iyo daryeelka caafimaadka ah oo adeegsata sirdoon macmal ah si ay u beddesho sida bukaanadu u bilaabaan una raacaan daaweynta. Madalkeennu wuxuu isku daraa adeegyada farmashiyaha, otomaatiga caqliga leh, iyo ka-qaybgalka xogta ku salaysan si loo wanaajiyo hababka daryeelka caafimaadka, loo hagaajiyo sii socoshada daryeelka, loona awoodsiiyo bukaanada inta lagu jiro koorsada daaweynta. Iyada oo la isku xidhayo farqiga u dhexeeya cilmiga nolosha, bixiyeyaasha daryeelka caafimaadka, iyo bukaanada, CaryHealth waxay kor u qaadaysaa helitaanka sinnaanta ee ilaha daryeelka caafimaadka waxayna ka caawisaa daaweyno kala duwan inay gaaraan awooddooda buuxda.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) waa shirkad daawo oo gaar ah oo diiradda saarta maqaarka oo leh faylal badan oo kala duwan oo ah badeecooyin iyo badeecooyin ganacsi oo horumar hore iyo mid dambe ah. Natroba™ oo ah nooca shatiga leh ee guud, spinosad, ayaa ah badeecooyinka kaliya ee helay magac "cad" oo loogu talagalay cudurka isnadaamiska oo ka yimid Maamulka Cuntada iyo Dawooyinka ee Mareykanka (FDA). Intaa waxaa dheer, Natroba™ (spinosad) waa daaweynta kaliya ee FDA ay ansixisay ee loogu talagalay injirta madaxa oo muujisay waxtar caafimaad oo heer sare ah marka la barbar dhigo Nix® (1% permethrin) laba tijaabo oo kiliinikada ah oo isbarbardhig ah Marxaladda III. Looma baahna shanleyn ukunta injirta.
Waqtiga boostada: Abriil-28-2026
